Exelixis | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 3.59B 1.96B 2025-03
Bayer EUR 3.71B 628M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Cytokinetics USD 57.37M 4.97M 2025-03
Eisai JPY 106.51B 1.99B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Exelixis USD 137.18M 2.86M 2025-04
Genmab DKK 126M 1.12B 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Incyte USD 325.69M 1.02M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.53B 319M 2025-03
Moderna USD 212M 139M 2025-03
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Sanofi EUR 1.24B 1.44B 2024-12
Takeda JPY 295.87B 25.28B 2025-03
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Xencor USD 17.34M 2.42M 2025-03



Exelixis Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.